- Design
- Ophthalmic technology assessment (structured literature review), 11 studies
- Population
- Patients having trabeculectomy with mitomycin C, mostly primary open-angle glaucoma
- Primary outcome
- Pressure control, surgical success and complications
- Effect
- Complete success 40.3% to 90.9% (injection) vs 17.7% to 86.5% (sponge); no difference in complications
An American Academy of Ophthalmology technology assessment in Ophthalmology (7 October) reviewed 11 studies comparing mitomycin C (MMC) given by sub-Tenon's or subconjunctival injection with application on sponges during trabeculectomy. Six studies were rated level I evidence.
Complete success in pressure control ranged from 40% to 91% with injection and 18% to 87% with sponges, and pressure reductions were similar, with the wide ranges reflecting different definitions and follow-up. Complication rates, including bleb leak, hypotony and choroidal effusion or haemorrhage, did not differ. Some studies reported fewer 5-fluorouracil injections and more diffuse, less vascular blebs with injection.
Injected MMC has gained popularity because it is quicker, gives a controlled dose and avoids retained sponges. This assessment supports either technique, so surgeons can use the one they are practised in. The bleb morphology advantage of injection is suggestive but not proven to improve long-term outcomes.
- Use either injected or sponge-applied mitomycin C at trabeculectomy, according to surgeon experience.
- Count sponges carefully if using the sponge technique to avoid retained material.
- Document MMC concentration and exposure, which varied widely across studies.
- Monitor bleb morphology and pressure closely in the early postoperative period with either method.
Why it matters
It removes uncertainty for surgeons switching to injection, which many find simpler.
The statistics, in plain English
This is a structured literature assessment, not a pooled meta-analysis, so it reports ranges rather than a single combined effect. The overlap of ranges indicates no consistent difference.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free